Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Public ClinicalTrials.gov record NCT02823951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the proportion of patients who demonstrate no medical need to discontinue therapy among DMT-naïve patients with relapsing forms of multiple sclerosis after 1 year of treatment with Rebif 44 mcg tiw or with Tecfidera 240 mg bid based on real-world data.
Study identification
- NCT ID
- NCT02823951
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 479 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2016 (Type not available)
- Primary completion
- Apr 2017 (Actual)
- Completion
- Feb 2018 (Actual)
- Last update posted
- Mar 1, 2018
2016 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Neurology Associates | Birmingham | Alabama | 35209 | — |
| Colorado Springs Neurological Associates | Colorado Springs | Colorado | 80907 | — |
| Savannah Neurology Specialists | Savannah | Georgia | 31406 | — |
| Northshore University | Evanston | Illinois | 60201 | — |
| OSF Multi-specialty Group d/b/a Illinois Neurological Institute | Peoria | Illinois | 61637 | — |
| St Elizabeths/ Dragonfly Research | Brighton | Massachusetts | 02135 | — |
| Lahey Clinic | Burlington | Massachusetts | 01805 | — |
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | — |
| Washington university | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Lincoln | Nebraska | 68588 | — |
| University of Buffalo Clinical and Translational research Center | Buffalo | New York | 14203 | — |
| Neurological Associates of Long Island | Lake Success | New York | 11042 | — |
| Onsite Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| Dayton Center for Neurological Disorders | Centerville | Ohio | 45459 | — |
| Oak Clinic-Multiple Sclerosis | Uniontown | Ohio | 44685 | — |
| Providence St. Vincent Medical Center | Portland | Oregon | 97228 | — |
| The university of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| University of Vermont | Burlington | Vermont | 05405 | — |
| Blacksburg Neurology | Christiansburg | Virginia | 24073 | — |
| MultiCare Health System | Tacoma | Washington | 98405 | — |
| Neuroscience Group | Neenah | Wisconsin | 54956 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02823951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02823951 live on ClinicalTrials.gov.